346 related articles for article (PubMed ID: 11350724)
1. The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification.
Prenzel N; Fischer OM; Streit S; Hart S; Ullrich A
Endocr Relat Cancer; 2001 Mar; 8(1):11-31. PubMed ID: 11350724
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine kinase signalling in breast cancer. Epidermal growth factor receptor: convergence point for signal integration and diversification.
Prenzel N; Zwick E; Leserer M; Ullrich A
Breast Cancer Res; 2000; 2(3):184-90. PubMed ID: 11250708
[TBL] [Abstract][Full Text] [Related]
3. The EGF receptor as central transducer of heterologous signalling systems.
Zwick E; Hackel PO; Prenzel N; Ullrich A
Trends Pharmacol Sci; 1999 Oct; 20(10):408-12. PubMed ID: 10577253
[TBL] [Abstract][Full Text] [Related]
4. The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities.
Yarden Y
Eur J Cancer; 2001 Sep; 37 Suppl 4():S3-8. PubMed ID: 11597398
[TBL] [Abstract][Full Text] [Related]
5. Receptor tyrosine kinase signalling as a target for cancer intervention strategies.
Zwick E; Bange J; Ullrich A
Endocr Relat Cancer; 2001 Sep; 8(3):161-73. PubMed ID: 11566607
[TBL] [Abstract][Full Text] [Related]
6. The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway.
Marques SA; Dy LC; Southall MD; Yi Q; Smietana E; Kapur R; Marques M; Travers JB; Spandau DF
J Pharmacol Exp Ther; 2002 Mar; 300(3):1026-35. PubMed ID: 11861812
[TBL] [Abstract][Full Text] [Related]
7. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptors: critical mediators of multiple receptor pathways.
Hackel PO; Zwick E; Prenzel N; Ullrich A
Curr Opin Cell Biol; 1999 Apr; 11(2):184-9. PubMed ID: 10209149
[TBL] [Abstract][Full Text] [Related]
9. Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology.
Pellat A; Vaquero J; Fouassier L
Hepatology; 2018 Feb; 67(2):762-773. PubMed ID: 28671339
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor dependence in human tumors: more than just expression?
Arteaga CL
Oncologist; 2002; 7 Suppl 4():31-9. PubMed ID: 12202786
[TBL] [Abstract][Full Text] [Related]
11. The epidermal growth factor/transforming growth factor-alpha family and their receptors.
Brown KD
Eur J Gastroenterol Hepatol; 1995 Oct; 7(10):914-22. PubMed ID: 8590134
[TBL] [Abstract][Full Text] [Related]
12. Trans-regulation of epidermal growth factor receptor by lysophosphatidic acid and G protein-coupled receptors.
Wu J; Cunnick JM
Biochim Biophys Acta; 2002 May; 1582(1-3):100-6. PubMed ID: 12069816
[TBL] [Abstract][Full Text] [Related]
13. The ErbB receptors and their ligands in cancer: an overview.
Normanno N; Bianco C; Strizzi L; Mancino M; Maiello MR; De Luca A; Caponigro F; Salomon DS
Curr Drug Targets; 2005 May; 6(3):243-57. PubMed ID: 15857286
[TBL] [Abstract][Full Text] [Related]
14. ErbB receptors and EGF-like ligands: cell lineage determination and oncogenesis through combinatorial signaling.
Pinkas-Kramarski R; Alroy I; Yarden Y
J Mammary Gland Biol Neoplasia; 1997 Apr; 2(2):97-107. PubMed ID: 10882296
[TBL] [Abstract][Full Text] [Related]
15. Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research.
Earp HS; Dawson TL; Li X; Yu H
Breast Cancer Res Treat; 1995 Jul; 35(1):115-32. PubMed ID: 7612898
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor family tyrosine kinases as signal integrators and therapeutic targets.
Barnes CJ; Kumar R
Cancer Metastasis Rev; 2003 Dec; 22(4):301-7. PubMed ID: 12884907
[TBL] [Abstract][Full Text] [Related]
17. Control of EGF receptor signalling: lessons from fruitflies.
Casci T; Freeman M
Cancer Metastasis Rev; 1999; 18(2):181-201. PubMed ID: 10728983
[TBL] [Abstract][Full Text] [Related]
18. Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage.
Rayego-Mateos S; Rodrigues-Diez R; Morgado-Pascual JL; Valentijn F; Valdivielso JM; Goldschmeding R; Ruiz-Ortega M
Mediators Inflamm; 2018; 2018():8739473. PubMed ID: 30670929
[TBL] [Abstract][Full Text] [Related]
19. EGFR signal transactivation in cancer cells.
Fischer OM; Hart S; Gschwind A; Ullrich A
Biochem Soc Trans; 2003 Dec; 31(Pt 6):1203-8. PubMed ID: 14641026
[TBL] [Abstract][Full Text] [Related]
20. Arsenite and arsenate activate extracellular signal-regulated kinases 1/2 by an epidermal growth factor receptor-mediated pathway in normal human keratinocytes.
Tanaka-Kagawa T; Hanioka N; Yoshida H; Jinno H; Ando M
Br J Dermatol; 2003 Dec; 149(6):1116-27. PubMed ID: 14674888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
